Condition reference
PainPain in pregnant or lactating patients
Explore the linked guideline and related drug references. A matching drug entry does not establish a treatment recommendation.
WSAVA guideline
Guidelines for the Recognition, Assessment and Treatment of Pain
Very little pharmacology data exists for analgesics in pregnant/lactating dogs and cats; this GPC sheet (adapted from Mathews et al. 2014) extrapolates partly from humans and lab species. The placenta is a lipoprotein barrier, so lipid-soluble drugs cross readily while polar, ionised, protein-bound or water-soluble drugs cross poorly; in lactation the neonate receives ~1–2% of the maternal dose in milk. Verdicts: opioids commonly used (prefer less lipid-soluble), NSAIDs avoided in pregnancy and single-dose-only in lactation, ketamine avoided in pregnancy (uterine tone), xylazine contraindicated, LAs highly recommended.
WSAVA Pain GL 2022/2023, doi 10.1111/jsap.13566; T34 protocol sheet adapted from GPC Treatise Mathews 2014
Key findings
- Maternal physiology alters pharmacology: ↓GI motility, reflux/vomiting; ↑cutaneous blood flow; ↑body water/fat; ↓serum albumin; altered hepatic enzymes; ↑renal function; placenta = lipoprotein barrier → polar/ionised/protein-bound/water-soluble drugs cross poorly (sheet).
- Opioids in pregnancy: commonly used; methadone, morphine, hydromorphone used in human pregnancy; fentanyl, pethidine, butorphanol, nalbuphine more lipid-soluble → higher foetal levels (sheet).
- Caesarean: most neonates deliver vigorous; if depressed → warmth, stimulation, O₂, suction ± a drop of naloxone sublingually (repeat doses may be needed) (sheet).
- ⚠️ Buprenorphine caused lack of milk production in animal studies — problematic post-caesarean (sheet).
- ⚠️ NSAIDs not given to pregnant animals (teratogenicity/development-interfering effects); ketamine crosses the placenta rapidly with no foetal effects observed in rats/mice/rabbits/dogs but increases uterine tone → avoid in pregnancy; α2-agonists reduce uterine blood flow — xylazine should not be used, no data for medetomidine/dexmedetomidine (sheet).
- Lactation: opioid milk transfer follows lipid solubility (pethidine > sufentanil > fentanyl > morphine > hydromorphone) — prefer hydrophilic morphine; suckle after peak levels wane; pethidine/butorphanol/nalbuphine not recommended; monitor dam + offspring. Local anaesthetics safe/non-teratogenic — highly recommended; if analgesia essential with toxicity concern, pump and discard milk 12 h and bottle-feed; herbals avoided (sheet).
Drugs named in WSAVA’s own guideline text
As printed in WSAVA’s document, not this app’s own extracted data — see “Related drugs in this reference” below for that.
Opioids — methadone, morphine, hydromorphone
Pregnancy: Commonly used — Lactation: Prefer morphine (hydrophilic, least milk); suckle after peak wanes — Monitor dam + offspring
Naloxone
Pregnancy: A drop sublingually for depressed neonates, repeat as needed — Lactation: — — With warmth/stimulation/O₂/suction
NSAIDs / paracetamol
Pregnancy: ⚠️ Avoid — teratogenic/development-interfering — Lactation: Single doses only, with caution (no lactating dog/cat studies) — Haemorrhage concern with non-COX-/COX-1-selective NSAIDs right after birth; paracetamol safe in dogs, never cats
Ketamine
Pregnancy: ⚠️ Avoid — increases uterine tone — Lactation: Expected in milk (no reports) — Crosses placenta rapidly
α2-agonists — xylazine / medetomidine / dexmedetomidine
Pregnancy: ⚠️ Xylazine contraindicated (uterine blood flow); no evidence for the others — Lactation: Not addressed — —
Local anaesthetics (lidocaine)
Pregnancy: ✅ Safe, non-teratogenic — highly recommended — Lactation: Small milk levels; incision-line infiltration highly recommended — —
Herbal analgesics
Pregnancy: ⚠️ Avoid (no information) — Lactation: ⚠️ Avoid — —
Recommendations
Opioids acceptable in pregnancy; prefer less lipid-soluble agents
Stated verdict (sheet)
No NSAIDs in pregnancy; avoid ketamine (uterine tone); xylazine contraindicated
Stated verdict (sheet)
Local anaesthetics highly recommended (pregnancy; incision-line in lactation)
Stated verdict (sheet)
Depressed neonate post-caesarean: support + drop of naloxone sublingually
Stated protocol (sheet)
Lactation: prefer hydrophilic opioids; NSAIDs single doses only (haemorrhage risk)
Stated verdict (sheet)
If concern: pump-and-discard milk 12 h, bottle-feed; avoid herbals
Stated protocol (sheet)
Related drugs in this reference (0)
No indication text currently matches this condition by name. Try a broader condition or search the drug reference directly. Absence of a match does not establish that treatment is unavailable.
Built from the 🤰 addendum of summaries/02-pain-2022.md, verified verbatim against the local GPC sheet (text/Pregnant-or-lactating-patients.txt; Mathews 2014) — still the current WSAVA resource here. The sheet is qualitative (class verdicts, no mg/kg doses); its only numeric values are the ~1–2% milk-transfer estimate and the 12 h pump-and-discard interval. The 2022 guideline touches this scenario only via CBD avoidance (§2.11).